SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. Howell, P. Angus, P. Gow, Hepatitis C recurrence: the Achilles heel of liver transplantation, Transplant Infectious Disease, 2014, 16, 1
  2. 2
    Kumiko Mera, Hirofumi Uto, Seiichi Mawatari, Akio Ido, Yozo Yoshimine, Tsuyoshi Nosaki, Kohei Oda, Kazuaki Tabu, Kotaro Kumagai, Tsutomu Tamai, Akihiro Moriuchi, Makoto Oketani, Yuko Shimada, Masaaki Hidaka, Susumu Eguchi, Hirohito Tsubouchi, Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C, BMC Gastroenterology, 2014, 14, 1, 27

    CrossRef

  3. 3
    Michał Kukla, Angiogenesis: a phenomenon which aggravates chronic liver disease progression, Hepatology International, 2013, 7, 1, 4

    CrossRef

  4. 4
    Stéphanie Pascarella, Sophie Clément, Michael T. Dill, Stéphanie Conzelmann, Martin Lagging, Gabriele Missale, Avidan U. Neumann, Jean-Michel Pawlotsky, Stefan Zeuzem, Laura Rubbia-Brandt, Pierre-Yves Bochud, Francesco Negro, Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C, Liver International, 2013, 33, 1
  5. 5
    Sanjaya Kumar Satapathy, Satheesh Nair, Jason M. Vanatta, Nonalcoholic fatty liver disease following liver transplantation, Hepatology International, 2013, 7, 2, 400

    CrossRef

  6. 6
    Michael T. Murray, Textbook of Natural Medicine, 2013,

    CrossRef

  7. 7
    Vincent Kaddai, Francesco Negro, Current understanding of insulin resistance in hepatitis C, Expert Review of Gastroenterology & Hepatology, 2011, 5, 4, 503

    CrossRef

  8. 8
    Jun Iwamoto, Azusa Seki, Yoshihiro Sato, Hideo Matsumoto, Tsuyoshi Takeda, James K. Yeh, Effect of vitamin K2 on cortical and cancellous bone mass and hepatic lipids in rats with combined methionine-choline deficiency, Bone, 2011, 48, 5, 1015

    CrossRef

  9. 9
    Rodolphe Anty, Maud Lemoine, Liver fibrogenesis and metabolic factors, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, S10

    CrossRef

  10. 10
    Argiro Voumvouraki, Mairi Koulentaki, George Notas, Ourania Sfakianaki, Elias Kouroumalis, Serum surrogate markers of liver fibrosis in primary biliary cirrhosis, European Journal of Internal Medicine, 2011, 22, 1, 77

    CrossRef

  11. 11
    Hanan M. Ahmed, Hala K. El-Shereef, Salwa S. El-Gendi, Wafaa T. El-Sherif, Madeeha Y. Bakheet, Ghada M. Galal, Sherif H. Abdel-Wahab, Omnia Abd El-Moneum, Leptin, osteocalcin, and bone mineral density in post-hepatitic liver cirrhosis, Arab Journal of Gastroenterology, 2010, 11, 3, 130

    CrossRef

  12. 12
    Fabio Marra, Cristiana Bertolani, Adipokines in liver diseases, Hepatology, 2009, 50, 3
  13. 13
    Inaam A. Nakchbandi, Schalk W. van der Merwe, Current understanding of osteoporosis associated with liver disease, Nature Reviews Gastroenterology & Hepatology, 2009, 6, 11, 660

    CrossRef

  14. 14
    B. J. Veldt, J. J. Poterucha, K. D. S. Watt, R. H. Wiesner, J. E. Hay, C. B. Rosen, J. K. Heimbach, H. L. A. Janssen, M. R. Charlton, Insulin Resistance, Serum Adipokines and Risk of Fibrosis Progression in Patients Transplanted for Hepatitis C, American Journal of Transplantation, 2009, 9, 6
  15. 15
    Caroline Hora, Francesco Negro, Giacchino Leandro, Carl M. Oneta, Laura Rubbia-Brandt, Beat Muellhaupt, Beat Helbling, Raffaele Malinverni, Jean-Jacques Gonvers, Jean-François Dufour, Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C, Liver International, 2008, 28, 3
  16. 16
    Wendong Chen, Terence Wong, George Tomlinson, Murray Krahn, E. Jenny Heathcote, Prevalence and predictors of obesity among individuals with positive hepatitis C antibody in a tertiary referral clinic, Journal of Hepatology, 2008, 49, 5, 711

    CrossRef

  17. 17
    J. J. BLONSKY, S. A. HARRISON, Review article: nonalcoholic fatty liver disease and hepatitis C virus – partners in crime, Alimentary Pharmacology & Therapeutics, 2008, 27, 10
  18. 18
    Emmanuel Tsochatzis, George V. Papatheodoridis, Emilia Hadziyannis, Anastasia Georgiou, Georgia Kafiri, Dina G. Tiniakos, Emanuel K. Manesis, Athanasios J. Archimandritis, Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity, Scandinavian Journal of Gastroenterology, 2008, 43, 9, 1128

    CrossRef

  19. 19
    Cristiana Bertolani, Fabio Marra, The role of adipokines in liver fibrosis, Pathophysiology, 2008, 15, 2, 91

    CrossRef

  20. 20
    Zhaoyang Ye, Houssam S. Hajj Houssein, Ram I. Mahato, Bioconjugation of Oligonucleotides for Treating Liver Fibrosis, Oligonucleotides, 2007, 17, 4, 349

    CrossRef

  21. 21
    Dawn M. Torres, Stephen A. Harrison, Hepatitis C, insulin resistance, and steatosis, Current Hepatitis Reports, 2007, 6, 4, 129

    CrossRef

  22. 22
    Ian Homer Y. Cua, Jason M. Hui, Priyanka Bandara, James G. Kench, Geoffrey C. Farrell, Geoffrey W. McCaughan, Jacob George, Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines, Hepatology, 2007, 46, 1
  23. 23
    Fabio Marra, Leptin and liver tissue repair: Do rodent models provide the answers?, Journal of Hepatology, 2007, 46, 1, 12

    CrossRef

  24. 24
    Andrew D. Clouston, Julie R. Jonsson, Elizabeth E. Powell, Steatosis as a Cofactor in Other Liver Diseases: Hepatitis C Virus, Alcohol, Hemochromatosis, and Others, Clinics in Liver Disease, 2007, 11, 1, 173

    CrossRef

  25. 25
    Theodoros A. Zografos, Eirini I. Rigopoulou, Christos Liaskos, Elias Togousidis, Kalliopi Zachou, Nikolaos Gatselis, Anastasios Germenis, George N. Dalekos, Alterations of leptin during IFN-α therapy in patients with chronic viral hepatitis, Journal of Hepatology, 2006, 44, 5, 848

    CrossRef

  26. 26
    Yan Shi, Guang Tao Yan, Ji Lin, Intestinal ischemia–reperfusion injury made leptin decreased, Regulatory Peptides, 2006, 133, 1-3, 27

    CrossRef

  27. 27
    Sotirios K. Bethanis, Stamatios E. Theocharis, Leptin in the Field of Hepatic Fibrosis: A Pivotal or an Incidental Player?, Digestive Diseases and Sciences, 2006, 51, 10, 1685

    CrossRef

  28. 28
    Emmanuel Tsochatzis, George V Papatheodoridis, Athanasios J Archimandritis, The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases, The American Journal of Gastroenterology, 2006, 101, 11, 2629

    CrossRef

  29. 29
    Sophie Lotersztajn, Boris Julien, Fatima Teixeira-Clerc, Pascale Grenard, Ariane Mallat, HEPATIC FIBROSIS: Molecular Mechanisms and Drug Targets, Annual Review of Pharmacology and Toxicology, 2005, 45, 1, 605

    CrossRef

  30. 30
    Nassim Kamar, Lionel Rostaing, Janick Selves, Karine Sandres-Saune, Laurent Alric, Dominique Durand, Jacques Izopet, La diversification de la région hypervariable-1 du virus de l'hépatite C pourrait prédire l'évolution de la fibrose hépatique après transplantation rénale, Néphrologie & Thérapeutique, 2005, 1, 6, 345

    CrossRef

  31. 31
    Nassim Kamar, Lionel Rostaing, Janick Selves, Karine Sandres-Saune, Laurent Alric, Dominique Durand, Jacques Izopet, Natural History of Hepatitis C Virus-Related Liver Fibrosis After Renal Transplantation, American Journal of Transplantation, 2005, 5, 7
  32. 32
    David S. Heppner, Stephen A. Harrison, Obesity, insulin resistance, and HCV: Implications for pathogenesis, Current Hepatitis Reports, 2005, 4, 4, 153

    CrossRef

  33. 33
    F. MARRA, S. ALEFFI, C. BERTOLANI, I. PETRAI, F. VIZZUTTI, Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis, Alimentary Pharmacology & Therapeutics, 2005, 22,
  34. 34
    Ferenc Szalay, Aniko Folhoffer, Andrea Horv??th, Timea Csak, Gabor Speer, Zsolt Nagy, Peter Lakatos, Csaba Horv??th, Andrzej Habior, Istvan Tornai, Peter Laszlo Lakatos, Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis, European Journal of Gastroenterology & Hepatology, 2005, 17, 9, 923

    CrossRef

  35. 35
    Keyur Patel, Amany Zekry, John G. McHutchison, Steatosis and Chronic Hepatitis C Virus Infection: Mechanisms and Significance, Clinics in Liver Disease, 2005, 9, 3, 399

    CrossRef

  36. 36
    Elizabeth E. Powell, Julie R. Jonsson, Andrew D. Clouston, Steatosis: Co-factor in other liver diseases, Hepatology, 2005, 42, 1
  37. 37
    Andrew D. Clouston, Julie R. Jonsson, Elizabeth E. Powell, Chronic hepatitis C and steatosis, Current Hepatitis Reports, 2004, 3, 4, 123

    CrossRef